Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Dermatologic Clinics
|
July 1, 1991
AIDS: a historical overview
C Farthing
The Body Positive
|
May 22, 2001
Adherence and double therapies: an interview with Charles Farthing, M.D. Interview by Marcelo Marer
C Farthing
Lancet (London, England)
|
April 20, 1985
Acute illnesses associated with HTLV-III seroconversion
C Farthing, B Gazzard
Seminars in Dermatology
|
June 1, 1990
Human immunodeficiency virus infection: a survey with special emphasis on mucocutaneous manifestations
A E Friedman-Kien, C Farthing
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 3, 2000
Development of Kaposi sarcoma despite sustained suppression of HIV plasma viremia
H Khanlou, T Stein, C Farthing
Archives of Internal Medicine
|
December 9, 2000
Reduction of buffalo hump by switching to amprenavir in an HIV-infected patient
H Khanlou, M Adair, C Farthing
Lancet (London, England)
|
February 15, 1992
Azithromycin for cerebral toxoplasmosis
C Farthing, M Rendel, B Currie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 6, 2001
Heterogeneity of patients' adherence profile to antiretroviral therapy in HIV-infected patients
B L Kennedy, J O'Malley, H Khanlou, et al.
Genitourinary Medicine
|
February 1, 1985
Two regimens of sultamicillin in treating uncomplicated gonorrhoea
C Farthing, R N Thin, S Smith, et al.
Public Health
|
November 21, 2012
Study on clinical epidemiology of male HIV/AIDS patients in a tertiary Chinese hospital, Shanghai, China
Y Zheng, H Lu, X Jiang, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Dermatologic Clinics
|
July 1, 1991
AIDS: a historical overview
C Farthing
The Body Positive
|
May 22, 2001
Adherence and double therapies: an interview with Charles Farthing, M.D. Interview by Marcelo Marer
C Farthing
Lancet (London, England)
|
April 20, 1985
Acute illnesses associated with HTLV-III seroconversion
C Farthing, B Gazzard
Seminars in Dermatology
|
June 1, 1990
Human immunodeficiency virus infection: a survey with special emphasis on mucocutaneous manifestations
A E Friedman-Kien, C Farthing
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 3, 2000
Development of Kaposi sarcoma despite sustained suppression of HIV plasma viremia
H Khanlou, T Stein, C Farthing
Archives of Internal Medicine
|
December 9, 2000
Reduction of buffalo hump by switching to amprenavir in an HIV-infected patient
H Khanlou, M Adair, C Farthing
Lancet (London, England)
|
February 15, 1992
Azithromycin for cerebral toxoplasmosis
C Farthing, M Rendel, B Currie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 6, 2001
Heterogeneity of patients' adherence profile to antiretroviral therapy in HIV-infected patients
B L Kennedy, J O'Malley, H Khanlou, et al.
Genitourinary Medicine
|
February 1, 1985
Two regimens of sultamicillin in treating uncomplicated gonorrhoea
C Farthing, R N Thin, S Smith, et al.
Public Health
|
November 21, 2012
Study on clinical epidemiology of male HIV/AIDS patients in a tertiary Chinese hospital, Shanghai, China
Y Zheng, H Lu, X Jiang, et al.
Page
of 3